Form 4: Alignment Healthcare CIO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Alignment Healthcare's Chief Information Officer, Robert L. Scavo, sold 4,044 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

  • Robert L. Scavo, Chief Information Officer of Alignment Healthcare, Inc. (ALHC), sold a total of 4,044 shares of common stock.
  • The sales occurred on March 12, 2026, and were non-discretionary, executed to cover tax withholding obligations from the vesting of restricted stock units.
  • One transaction involved 3,799 shares sold at a weighted-average price of $17.476 per share, with prices ranging from $17.035 to $18.03.
  • A second transaction involved 245 shares sold at a weighted-average price of $16.9919 per share, with prices ranging from $16.92 to $17.03.
  • Following these transactions, Mr. Scavo beneficially owns 498,970 shares of Alignment Healthcare common stock directly.
  • The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine, non-discretionary transaction for tax purposes, not reflecting a change in management's confidence or a strategic divestment.

Positives

  • The sale was non-discretionary and for tax withholding, indicating a routine event rather than a lack of confidence in the company.
  • The reporting person still holds a significant number of shares (498,970), demonstrating continued alignment with shareholder interests.

Future Outlook

NA

Management Comments

  • Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

Industry Context

StockSavvy.ai notes that routine insider sales for tax withholding purposes, especially when tied to vesting restricted stock units and executed under a 10b5-1 plan, are common across various industries, including healthcare. These transactions are generally not indicative of management's sentiment towards the company's future performance but rather a standard compensation and tax management practice.

Comparison to Industry Standards

  • The sale of shares to cover tax obligations upon RSU vesting is a standard practice for executives across publicly traded companies, including those in the healthcare sector like UnitedHealth Group, Elevance Health, or Cigna.
  • The use of a Rule 10b5-1 plan for such transactions is also a common corporate governance practice, providing an affirmative defense against insider trading allegations by pre-scheduling trades.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy AdherenceThe transaction was executed under a Rule 10b5-1(c) plan, demonstrating adherence to corporate governance best practices for insider trading by pre-scheduling non-discretionary sales.03/12/2026Enhances transparency and mitigates potential concerns regarding insider trading, aligning with regulatory expectations.

Related Party Transactions

  • The sale of shares by a Chief Information Officer (an insider) is inherently a related party transaction, though routine for compensation and tax purposes.

Stakeholder Impact

  • Shareholders: Minimal direct impact as the sale is routine for tax purposes and not a discretionary divestment. The officer retains a substantial holding.
  • Employees: No direct impact mentioned.
  • Management: The transaction reflects standard compensation and tax management practices for executives.

Key Dates

DateDescription
03/12/2026Date of earliest transaction (sale of common stock).
03/13/2026Date of signature by Attorney-in-Fact for Robert L. Scavo.

Recommendation

hold

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations related to RSU vesting. Such transactions, especially when executed under a 10b5-1 plan, are common and generally do not signal a change in the company's fundamentals or management's outlook. Therefore, it provides no new information that would warrant a change in investment recommendation; a "hold" stance is appropriate as this event is neutral.

Keywords

Alignment Healthcare, ALHC, Robert L. Scavo, Chief Information Officer, CIO, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, RSU, 10b5-1 plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.